Imininingwane Yamabhulogi
Ukubuka: 0 Umbhali: Isikhathi Sokushicilela Isihleli Sesayithi: 2024-07-29 Umsuka: Isayithi
Uma ukhuluphele noma unenkinga yokulahlekelwa isisindo, ungase ubuze ukuthi umjovo we-semaglutide ungakusiza yini ulahlekelwe isisindo. Ucwaningo lwakamuva lubonisa imiphumela enamandla. Ocwaningweni olulodwa olukhulu, abantu abadala balahlekelwe cishe yi-14.9% yesisindo somzimba wabo ngomjovo we-semaglutide . Abantu abangaphezu kuka-86% balahlekelwa okungenani u-5% wesisindo sabo. Abantu abangaphezu kuka-80% abasebenzisa lokhu kwelashwa bagcina isisindo sehlile ngemva konyaka. Ishadi elingezansi libonisa ukuthi kanjani Umjovo we-semaglutide usebenza uma uqhathaniswa ne-placebo emaqenjini ahlukene:
Isivivinyo |
Inani labantu |
Umthamo we-Semaglutide |
Ubude besikhathi |
Kusho Ukulahlekelwa Kwesisindo (%) Semaglutide |
Mean Weight Loss (%) Placebo |
Okutholakele Okubalulekile |
ISINYATHELO 1 |
Abantu abadala abangenaso isifo sikashukela |
2.4 mg ngesonto |
68 amasonto |
14.9 |
2.4 |
Abantu abaningi behla emzimbeni; ama-86.4% alahlekelwe okungenani ngama-5%; inhliziyo nempilo yaba ngcono. |
ISINYATHELO 2 |
Abantu abadala abanesifo sikashukela sohlobo 2 |
2.4 mg ngesonto |
68 amasonto |
9.6 |
3.4 |
Abantu abanesifo sikashukela balahlekelwa isisindo esincane kunabanye; inhliziyo nempilo yaba ngcono. |
ISINYATHELO 3 |
Abantu abadala abangenaso isifo sikashukela + IBT |
2.4 mg ngesonto |
68 amasonto |
16.0 |
N/A |
Ukwelashwa okwengeziwe kwasiza abantu ukuba balahlekelwe isisindo ngokushesha ekuqaleni kodwa hhayi ngaphezulu ngemva kwamasonto angu-68. |
ISINYATHELO 6 |
Abantu abadala base-East Asia (abanesifo sikashukela/abangenaso isifo sikashukela) |
2.4 mg ngesonto |
68 amasonto |
13.2 |
2.1 |
I-Semaglutide isebenze kahle kubantu abadala base-East Asia; balahlekelwa isisindo esingaphansi kancane kuneSINYATHELO 1. |
ISINYATHELO 8 |
Abantu abadala abangenaso isifo sikashukela |
2.4 mg ngesonto |
68 amasonto |
15.8 |
N/A |
I-Semaglutide isebenze kangcono kune-liraglutide; abantu abaningi balahlekelwa ngo-10%, 15%, noma 20% wesisindo sabo. |

Kufanele ucabange ngezingozi nezinzuzo ngaphambi kokuqala noma yiluphi uhlelo olusha lokulahlekelwa isisindo. Khuluma nodokotela wakho ukuze ubone ukuthi umjovo we-semaglutide ulungile yini kuwe, ikakhulukazi uma ukhuluphele noma unezinye izinkinga zempilo.
Umjovo we-Semaglutide usiza abantu ukuthi balahlekelwe isisindo esiningi. Abantu abaningi balahlekelwa cishe amaphesenti angu-15 esisindo somzimba wabo ngonyaka owodwa.
Umuthi wehlisa indlala futhi ubambezela ukuthi isisu sakho siphuma ngokushesha kangakanani. Kuyasiza futhi ukulawula ushukela egazini. Lokhu kwenza kube lula ukudla ukudla okuncane. Uzizwa ugcwele isikhathi eside.
Ukusebenzisa i-semaglutide ngokudla okunempilo nokuzivocavoca okuvamile kukusiza ukuthi ulahlekelwe isisindo esiningi. Iphinde ikusize ugcine isisindo singekho isikhathi eside.
I-Semaglutide inikeza ezinye izinzuzo zezempilo ngaphandle kokulahlekelwa isisindo. Kuyasiza ukulawula ushukela wegazi kangcono. Yehlisa amathuba okuba nezinkinga zenhliziyo.
Khuluma nodokotela wakho ngaphambi kokuba uqale ukusebenzisa i-semaglutide. Lokhu kuqinisekisa ukuthi iphephile kuwe. Udokotela wakho uzokufundisa ukuthi ungayisebenzisa kanjani ngendlela efanele ukuze uthole imiphumela engcono kakhulu.

Kungenzeka ukuthi uzwile mayelana umjovo we-semaglutide . Kuyisinqumo esisha sokwehlisa isisindo. Lo muthi uyingxenye yama-GLP-1 receptor agonists. Isiza abantu abakhuluphele noma abadinga usizo lokuncipha. I-Semaglutide itholakala e-Wegovy nase-Ozempic. I-Ozempic yokwehlisa isisindo idumile. Udinga ukuyisebenzisa kanye ngesonto. Lokhu kulula kunezidakamizwa ezindala zokunciphisa umzimba.
Nali ithebula elibonisa ukuthi i-semaglutide iqhathaniswa kanjani nezinye izidakamizwa zokulahlekelwa isisindo:
Imithi |
I-Pharmacological Class |
Ukusetshenziswa Okugunyaziwe |
Ukuphatha |
I-Dosing Frequency |
I-Semaglutide |
I-GLP-1 receptor agonist |
Isifo sikashukela sohlobo 2, Ukukhuluphala |
Umjovo (Wegovy, Ozempic), Oral (Rybelsus) |
Kanye ngeviki (umjovo), Nsuku zonke (ngomlomo) |
I-Tirzepatide |
I-Dual GLP-1 kanye ne-GIP receptor agonist |
Ukukhuluphala, Uhlobo 2 sikashukela |
Umjovo |
Kanye ngesonto |
I-Liraglutide |
I-GLP-1 receptor agonist |
Isifo sikashukela sohlobo 2, Ukukhuluphala |
Umjovo |
Kanye ngosuku |
I-Phentermine |
I-Sympathomimetic amine |
Ukuncipha kwesisindo |
I-Oral (ithebhulethi, i-capsule) |
Nsuku zonke (kuyahlukahluka) |
I-Semaglutide yokulahlekelwa isisindo ikhethekile. Isebenza kokubili uhlobo 2 sikashukela kanye nokukhuluphala. I-Ozempic yokwehlisa isisindo futhi i-Wegovy isebenzisa i-semaglutide. Umjovo ufika ngepeni. Uyisebenzisa kanye ngesonto. Kukusiza ukuthi ulahlekelwe isisindo futhi ungagcini. Udinga ukudla okunempilo futhi uhambise kakhudlwana ukuze uthole imiphumela engcono kakhulu.
Ungase uzibuze ukuthi umjovo we-semaglutide usiza kanjani ulahlekelwe isisindo. Isebenza njengehomoni ebizwa nge-GLP-1. Le hormone ilawula indlala noshukela egazini. I-Semaglutide yokuncipha kwesisindo ivula ama-GLP-1 receptors ebuchosheni bakho nakumanyikwe. Lokhu kubangela izinguquko ezibalulekile:
1. Kwenza ukuthi ungalambi ngokusebenza ebuchosheni bakho.
2. Kunciphisa isisu sakho ukuze uzizwe ugcwele isikhathi eside.
3. Isiza amanyikwe akho enze i-insulin eyengeziwe lapho ushukela wakho wegazi ukhuphuka.
4. Yehlisa iglucagon, ngakho isibindi sakho sifaka ushukela omncane egazini lakho.
5. Kusiza umzimba wakho ukuthi usebenzise amandla amaningi, ashisa amafutha.
Ithiphu: I-Semaglutide ihlala isikhathi eside emzimbeni wakho. Udinga kuphela ukujova kanye ngesonto. Lokhu kwenza kube lula ukulandela uhlelo lwakho lokwehlisa isisindo.
I-Ozempic yokwehlisa isisindo futhi i-Wegovy isebenza ngale ndlela. Bakusiza ukuthi ulahlekelwe isisindo esiningi. Basekela izimpawu zomzimba wakho zokulamba nokusutha. Umjovo we-Semaglutide awubangeli ukwehla okusheshayo kushukela wegazi. Isebenza kancane, ngakho-ke ubona izinguquko eziqhubekayo.
Abantu abaningi banenkinga ngezifiso nokudla ngokomzwelo. I-Semaglutide yokulahlekelwa isisindo isiza ukulawula le mizwa ebuchosheni bakho. Uzizwa ugcwele ukudla okuncane. Ufuna ukudla okunekhalori ephezulu okuncane. Ucwaningo lukhombisa ukuthi abantu abasebenzisa umjovo we-semaglutide bane:
Ukuncipha kokulamba kanye nokuncipha kokulangazelela ukudla okunosawoti, okumnandi, noma okunamafutha
Ukulawula okwengeziwe kokudla okungokomzwelo nokudla ngokweqile
Yehlisa isifiso sokudla okulula okunamandla amaningi
Ucwaningo lubonise ukudla okungokomzwelo kwehle kusuka ku-72.5% kuya ku-11.5% ngemva kwezinyanga ezintathu. Izifiso zokudla zehlile zisuka ku-49.3% zaya ku-21.7%. Abantu badla kancane futhi bazizwa besuthi isikhathi eside. Lokhu kukusiza ukuthi ulahlekelwe isisindo futhi ungagcini.
I-Semaglutide yokulahlekelwa isisindo iphinde ishintshe indlela umzimba wakho osabela ngayo kumahomoni alambile. Igcina indlala iphansi nokugcwala kuphezulu, ngisho nangemva kokuba ulahlekelwe isisindo. Izidlo eziningi zikwenza ulambe ngemva kokulahlekelwa isisindo, kodwa i-semaglutide ihlukile.
Ungabona izinguquko zangempela ngomjovo we-semaglutide . Ucwaningo lubonisa:
Ezinyangeni ezi-3: ukuncipha kwesisindo okumaphakathi cishe ku-9.6% wesisindo sakho sokuqala
Ezinyangeni eziyisi-6: isilinganiso sokuncipha kwesisindo singu-10.9% kuya ku-13.8%
Ezinyangeni ezingu-12: isilinganiso sokulahlekelwa isisindo singu-13.4% kuya ku-17%, ikakhulukazi ngemikhuba enempilo
Cishe u-23.5% wabantu behla ngo-15% noma ngaphezulu wesisindo somzimba wabo ngezinyanga eziyisi-6
Ukuncipha kwesisindo kwenzeka kancane, cishe amakhilogremu angu-1-2 isonto ngalinye. Abantu abaningi bayayeka ukuncipha ngemva kwezinyanga ezingu-9 kuya kweziyi-12. Kodwa bagcina u-10% kuya ku-15% wesisindo sabo sokuqala.
Umjovo we-Semaglutide usebenza kangcono kunezinye izidakamizwa eziningi zokulahlekelwa isisindo. I-Ozempic yokwehlisa isisindo futhi i-Wegovy inikeza imiphumela engcono kune-liraglutide noma i-dulaglutide. I-Tirzepatide isidakamizwa esisha. Kungase kukusize ulahlekelwe isisindo esiningi. Kodwa i-semaglutide iseyisinqumo esiphezulu kubantu abaningi.
Ukuqhathanisa |
Umehluko Wokuncipha Kwesisindo (kg) |
Amanothi |
I-Tirzepatide vs Semaglutide |
- 3.78 kg |
I-Tirzepatide isiza abantu ukuthi balahlekelwe isisindo ngokushesha. |
I-Semaglutide vs Liraglutide |
-6.08 kg |
I-Semaglutide isiza abantu ukuthi balahlekelwe isisindo esiningi kune-liraglutide. |
I-Tirzepatide vs Semaglutide & Liraglutide |
-8.47 kg (isisindo somzimba) |
I-Tirzepatide umuthi osebenza kakhulu we-GLP-1. |

Uma ufuna ukuzama i-semaglutide, khumbula ukuthi isebenza kangcono ngokudla okunempilo nokuzivocavoca. I-Ozempic yokwehlisa isisindo kanye ne-Wegovy angamathuluzi aqinile abantu abadinga usizo olwengeziwe kunokushintsha indlela yokuphila. Lesi sidakamizwa sikunikeza ithuba elihle lokulahlekelwa isisindo esiningi futhi usigcine.
Umjovo we-Semaglutide wenza okungaphezu kokusiza ukuthi ulahlekelwe isisindo. Ikunikeza izinzuzo eziningi zezempilo ezingekho nje ngenombolo esikalini. Lezi zinguquko zingakusiza uzizwe unempilo futhi wehlise ingcuphe yokugula okubi kakhulu. Benza futhi kube lula ukuphila impilo engcono. Ake sibheke ukuthi i-semaglutide ingasiza kanjani impilo yakho ngezindlela eziningi.
Uma usebenzisa i-semaglutide, i-metabolism yomzimba wakho ingaba ngcono. Kusiza umzimba wakho ugcine ushukela osegazini usezingeni elinempilo. Futhi kusiza amaseli akho ukuthi asebenzise i-insulin ngendlela efanele. Lezi yizindaba ezinhle uma unesifo sikashukela sohlobo 2 noma ushukela ophezulu wegazi.
Ipharamitha |
Intuthuko Iboniwe |
Ukunciphisa ushukela wegazi ngokushesha |
22% yehla |
Iglucose yegazi amahora ama-2 ngemuva kokudla |
36% yehla |
Iglucose yegazi amahora angama-24 |
22% yehla |
Ukukhiqizwa kwe-insulin kwesigaba sokuqala nesesibili |
Ikhuphukele kumaleveli afana nabantu abanempilo |
Ukukhishwa kweGlucagon ngesibindi (ukuzila ukudla) |
Kwehliswe ngo-8% |
Ukukhishwa kwe-glucagon ngemuva kokudla |
Kwehliswe ngo-14-15% |
I-Glucagon ikhishwa amahora angama-24 |
Kwehliswe ngo-12% |


I-Semaglutide isiza ushukela wakho wegazi ukuthi uhlale uzinzile usuku lonke. Kwenza umzimba wakho ukhiphe i-insulin eningi uma udla. Yehlisa noshukela esenziwa yisibindi sakho. Abantu abaningi babona ushukela wegazi ongcono emasontweni ambalwa nje. Ungase uzizwe unamandla futhi ungalambi. Lezi zinguquko zisiza ukwehlisa ingozi yezinkinga zesifo sikashukela.
I-Semaglutide iphinde isebenze kumaseli amafutha. Kuwenza abe mancane futhi ehlise amahomoni afana ne-leptin ne-resissin. Lawa mahomoni angenza kube nzima ngomzimba wakho ukusebenzisa i-insulin. Umzimba wakho ushisa amafutha amaningi futhi ugcine amafutha amancane ezithweni zakho. Ungabona ama-triglycerides aphansi kanye nokusetshenziswa okungcono kwe-insulin. Abantu abasebenzisa i-semaglutide bavame ukudinga i-insulin encane futhi balahlekelwe isisindo esiningi. Lezi zinguquko zenza kube lula ukuphatha i-metabolic syndrome futhi zikusize uzizwe ungcono.
I-Semaglutide ingasiza ukuvikela inhliziyo yakho nemithambo yegazi. Yehlisa ingozi yokuhlaselwa yinhliziyo, unhlangothi, nezinye izinkinga ezinkulu zenhliziyo. Ngisho noma i-cholesterol yakho nomfutho wegazi kungashintshi kakhulu, usathola izinzuzo eziqinile zenhliziyo.
Umphumela Wenhliziyo |
Ukunciphisa nge-Semaglutide (Wegovy) vs Placebo |
Izinkinga ezinkulu zenhliziyo (isifo senhliziyo, isifo sohlangothi, ukufa kwenhliziyo) |
20% ingozi ephansi |
Ukuhlaselwa yinhliziyo |
28% ukwehliswa |
Imivimbo engabulali |
7% ukuncishiswa |
Ukufa okuhlobene nenhliziyo |
Ukunciphisa ngo-15%. |
Ukufa okuyimbangela yonke |
Ukwehliswa ngo-19%. |


Lezi zinzuzo zenhliziyo zenzeka ngoba i-semaglutide yehlisa ukuvuvukala emzimbeni wakho. Kuyasiza futhi izitho zakho ukuthi zisebenze kangcono. Isekela inhliziyo, isibindi nezinso zakho. Ungase wehle cishe ngamakhilogremu angu-15, okusiza nenhliziyo yakho. Odokotela manje basebenzisa i-semaglutide ukuze basize abantu abadinga ukuvikeleka okwengeziwe kwenhliziyo, ikakhulukazi uma usebenzisa i-ozempic noma imithi efanayo yokwehlisa isisindo.
Qaphela: Ucwaningo lubonisa ukuthi i-semaglutide ayishintshi i-cholesterol noma umfutho wegazi kakhulu. Izinzuzo zenhliziyo zivela ekunciphiseni isisindo kanye nokuvuvukala kancane, hhayi ekushintsheni izinombolo ze-cholesterol.
Kungaba nzima ukugcina isisindo, kodwa i-semaglutide ikusiza ukuthi ugcine imiphumela yakho. Ungagcina ukuncipha uma uyisebenzisa ngemikhuba enempilo. Ucwaningo lubonisa abantu abayeka i-semaglutide kancane kancane futhi baqhubeke nemikhuba emihle bathola isisindo esincane kakhulu.
Ucwaningo olulodwa lubuke abantu abayeke i-semaglutide ngaphezu kwamasonto ayisishiyagalolunye. Ngemva kokuyeka, abaningi bagcina isisindo sabo siqinile izinyanga eziyisithupha. Ngokwesilinganiso, bagcina u-1.5% wesisindo sabo sokuqala. Uma uqhubeka nokunyakaza futhi udla ukudla okunempilo, ungakwazi ukugcina isisindo sakho sehlile isikhathi eside.
Isivivinyo/Isici |
Ukungenelela |
Umphumela Wokulahlekelwa Kwesisindo |
Ubufakazi Bomphumela Oqhubekayo |
Amanothi Engeziwe |
ISINYATHELO 1 & 3 |
I-Semaglutide 2.4 mg + indlela yokuphila |
Ukuncipha kwesisindo: ~ 15% kuya ku-16% |
Ukulahlekelwa kwesisindo okuphawulekayo kugcinwe ngaphezu kwamaviki angu-68 |
Izilinganiso ze-Odds zokuthi ≥5% ukuncipha kwesisindo: kufika ku-11.2; ngo-≥15% ukuncipha kwesisindo: kufika ku-19.3 |
ISINYATHELO 2 |
I-Semaglutide 2.4 mg + indlela yokuphila (T2D) |
Isilinganiso somehluko wokulahlekelwa isisindo uma kuqhathaniswa ne-placebo: 6.2% |
Ukusebenza okubonisiwe ezigulini ezinesifo sikashukela sohlobo 2 |
Isilinganiso sezinto ezingavamile ≥5% ukuncipha kwesisindo: 4.9; ngo-≥15% ukuncipha kwesisindo: 7.7 |
ISINYATHELO 4 |
I-semaglutide eqhubekayo vs i-placebo ngemva kokulahlekelwa isisindo sokuqala |
Umehluko wokwelashwa: I-14.8% ithanda ukuqhubeka kwe-semaglutide |
Kuboniswe ukubaluleka kwe-semaglutide eqhubekayo yokugcina isisindo |
Iziguli ezishintshela ku-placebo zaphinde zathola isisindo, ukuqinisekisa umphumela oqhubekayo kudinga ukwelashwa okuqhubekayo |
Indlela Yokuphila Yedwa |
Ukungenelela kwendlela yokuphila kuphela |
Ngokuvamile 4.0% kuya ku-10.9% ukulahlekelwa kwesisindo |
Isisindo sibuye sijwayelekile ngaphandle kwe-pharmacotherapy |
Indlela yokuphila ihlanganisa ukushoda kwekhalori nokusebenza komzimba; ISINYATHELO 3 sasinokwelashwa okujulile kokuziphatha |
Isincomo somhlahlandlela |
I-American Gastroenterological Association (2022) |
I-Semaglutide ibekwe phambili ngaphezu kwamanye ama-anti-obesity meds yokwelashwa kwesikhathi eside |
Isekela i-semaglutide njenge-adjunct endleleni yokuphila yokuphathwa kwesisindo esingapheli |
Ibonisa ukuphepha, ukubekezelelana, nokusebenza okuphakeme kwe-semaglutide ngaphezu kwendlela yokuphila yodwa |


Uthola imiphumela engcono kakhulu uma usebenzisa i-semaglutide ngokuzivocavoca nokudla okunempilo. Ochwepheshe bathi kufanele uzame ukunyakaza okungenani imizuzu engu-250 isonto ngalinye. Ukudla ukudla okunamaprotheni amaningi kukusiza uzizwe ugcwele. Ukuthola usizo kudokotela wakho noma umqeqeshi kungakusiza ukuthi unciphise isisindo. I-Ozempic kanye nemithi efanayo isebenza kangcono uma isetshenziswa isikhathi eside ukusiza ukulawula isisindo sakho.
Uthi bewazi?
I-Guangzhou AOMA Biological Technology Co., Ltd. ingumholi kwezobuhle bezokwelapha. Bangochwepheshe kuma-dermal fillers, i-mesotherapy, i-PDRN mesotherapy, kanye ne-skincare yezokwelapha. Le nkampani futhi inikeza izinsizakalo ze-CTO nezinketho zelebula ezizimele. Uma ufuna ukufunda kabanzi mayelana nemibono emisha yobuhle bezokwelapha noma unemibuzo, ungacela ithimba labo ukuze likunikeze iseluleko.
Ungabona ukuthi izinzuzo zezempilo ze-semaglutide zingaphezu nje kokulahlekelwa isisindo. Isiza i-metabolism yakho, ivikele inhliziyo yakho, futhi ikusize ugcine isisindo. Lezi zinzuzo zenza ukukhetha okuhle kwe-semaglutide ne-ozempic kubantu abafuna ukunciphisa umzimba futhi bazizwe bengcono isikhathi eside.
Ungase ubuze ukuthi umjovo we-semaglutide uyisinqumo esihle kuwe. Odokotela banemithetho ethile yokunquma ukuthi ubani ongayisebenzisa ekunciphiseni isisindo. I-Semaglutide ingeyabantu abadala abanokukhuluphala ngokweqile. Uma inkomba yesisindo somzimba wakho (BMI) ingama-30 noma ngaphezulu, ungayisebenzisa. Ungayisebenzisa futhi uma i-BMI yakho inama-27 noma ngaphezulu futhi unenkinga yezempilo ngenxa yokukhuluphala ngokweqile, njengomfutho wegazi ophakeme noma isifo sikashukela sohlobo 2. Izingane ezineminyaka engu-12 noma ngaphezulu zingasebenzisa i-semaglutide uma i-BMI yazo ingaphezu noma ngaphezu kwe-95th percentile yobudala babo nobulili.
Nawa amaphuzu abalulekile okuthi ubani ongayisebenzisa:
Abantu abadala abane-BMI engama-30 noma ngaphezulu.
Abantu abadala abane-BMI engama-27 noma ngaphezulu kanye nenkinga yezempilo ngenxa yesisindo.
Izingane ezineminyaka engu-12 noma ngaphezulu ezihlangabezana nomthetho we-BMI.
Udinga incwadi kadokotela wakho.
Kufanele ujoyine uhlelo lokunciphisa umzimba ngokudla okunempilo nokuzivocavoca.
Odokotela bavame ukunikeza i-semaglutide kubantu abanokukhuluphala kanye nezinkinga zenhliziyo. Kungasiza ukwehlisa amathuba okuhlaselwa yinhliziyo nokushaywa unhlangothi. Abantu abakhuluphele kanye nesifo sikashukela sohlobo 2 nabo bangaluthola usizo. I-Semaglutide isebenza kahle ekulahlekeni kwesisindo futhi isiza abantu kula maqembu ukuba babe nempilo.
Abanye abantu akufanele basebenzise umjovo we-semaglutide . Udinga ukwazi uma unezinkinga zempilo ezenza lesi sidakamizwa singaphephile. Odokotela babheka umlando wakho wezempilo ngaphambi kokuba uqale umuthi wokunciphisa umzimba.
Contraindication |
Incazelo |
Umlando womuntu siqu noma womndeni we-Medullary Thyroid Carcinoma (MTC) |
Ingozi ephezulu yomdlavuza wegilo. |
I-Multiple Endocrine Neoplasia syndrome uhlobo 2 (MEN 2) |
I-Genetic disorder ephakamisa ingozi yomdlavuza we-thyroid. |
Ukusabela okunamandla kwe-allergic ku-semaglutide noma izithako zayo |
Kufanele ukugweme uma ube nokungezwani okukhulu nalesi sidakamizwa. |
Ukuphazamiseka okukhulu kwamathumbu |
Kungase kwenze izinkinga zesisu zibe zimbi kakhulu njengokucanuzela kwenhliziyo noma ukuhlanza. |
Ukukhulelwa nokuncelisa |
Ukuphepha akucaci, ngakho odokotela abakuncomi. |
Ubudala obungaphansi kweminyaka engu-12 |
I-Semaglutide ayivunyelwe izingane ezincane. |
Izifo zesibindi noma izinso |
Odokotela bangase balungise umthamo wakho noma bakugweme. |
Ukusebenzisana kwezidakamizwa |
Eminye imithi ingasebenzisana futhi iguqule indlela i-semaglutide esebenza ngayo. |


Kufanele ukhulume nodokotela wakho ngomlando wakho wezempilo. Ezinye izidakamizwa, ezifana ne-blood thinners, imithi yesifo sikashukela, namaphilisi e-thyroid, zingaxubana ne-semaglutide. Udokotela wakho uzokusiza wazi ukuthi kuphephile yini kuwe.
Ithiphu: Njalo tshela udokotela wakho mayelana nempilo yakho kanye nayo yonke imithi yakho ngaphambi kokuqala noma yimuphi umuthi wokunciphisa umzimba. Lokhu kusiza udokotela wakho ukuthi akugcine uphephile futhi unempilo.
Udinga ukukhetha indawo efanele yakho umjovo we-semaglutide . Izindawo ezinhle kakhulu ingalo yakho engenhla, ithanga, noma isisu. Ungakwazi ukushintshanisa lawa masayithi isonto ngalinye. Lokhu kusiza ukuvimbela izinkinga zesikhumba futhi kugcina umuthi usebenza kahle. Hlanza indawo ngaphambi kokujova. Uma usebenzisa i-Ozempic ukwehlisa isisindo noma i-Wegovy, hlala uhlola isikhumba ukuthi sibomvu noma sivuvukele.
Thatha ipeni lakho le-semaglutide ngaphandle kwefriji. Ivumele ifinyelele izinga lokushisa legumbi. Hlola ilebula nosuku lokuphelelwa yisikhathi. Susa ikepisi bese unamathisela inaliti entsha. Qiniseka ukuthi iwindi lethamo libonisa inani elilungile. Ungasebenzisa ithebula elingezansi ukuze ubone ukuthi umthamo ushintsha kanjani ngokuhamba kwesikhathi ukuze unciphise isisindo nesifo sikashukela:
Isigaba |
Ibanga Lomthamo Lokuncipha Kwesisindo (Wegovy®) |
Ibanga Lomthamo Lohlobo 2 Lwesifo Sikashukela (Ozempic®) |
Amanothi Nge-Titration Nokugcinwa |
Ukuqala Dose |
0.25 mg masonto onke amaviki angu-4 |
0.25 mg masonto onke amaviki angu-4 |
Umthamo oyisingeniso ukuze unciphise imiphumela emibi |
Isigaba se-Titration |
Nyusa ku-0.5 mg ngesonto |
Nyusa ku-0.5 mg ngesonto |
Igcinwe okungenani amaviki angu-4, ilungiswe ngokubekezelelana |
Umthamo Wokwelapha |
Kufika ku-2.4 mg ngesonto |
Ngokujwayelekile 1.0 mg kuya ku-2.0 mg masonto onke |
Ukuncipha kwesisindo umthamo omkhulu kunokuphathwa isifo sikashukela |
Isondlo |
0.5 mg kuya ku-2.4 mg masonto onke noma biweekly |
0.5 mg kuya ku-2.0 mg masonto onke noma biweekly |
Umthamo ulungisiwe ngokusekelwe empendulweni yomuntu ngamunye |
Bamba ipeni linganyakazi. Ncinza isikhumba ngobumnene. Faka inaliti ngqo phakathi. Cindezela inkinobho ukuze ukhulule umthamo. Ungase uzwe ingcosana encane. Bala kancane kancane ufike kwesithupha. Lokhu kusiza umthamo ogcwele ungene emzimbeni wakho.
Gcina ipeni licindezelwe esikhumbeni sakho kuze kube yilapho iwindi lethamo likhombisa u-zero. Linda imizuzwana embalwa ngaphambi kokukhipha inaliti. Lesi sinyathelo siqinisekisa ukuthi uthola inani eligcwele lomjovo we-semaglutide . Ingxenye yomthamo engekho inganciphisa umphumela.
Susa inaliti bese uyibeka esitsheni esibukhali. Phinda ufake ikepisi lepeni. Gcina ipeni efrijini uma unemithamo eyengeziwe esele. Ungalokothi usebenzise izinaliti futhi. Njalo sebenzisa omusha ngomjovo ngamunye.
Hlola indawo yomjovo ukuthi ibomvu noma ivuvukele. Ungasebenzisa indwangu epholile uma uzwa ubuhlungu. Abantu abaningi bazizwa bephilile ngemva kokudubula. Uma uzizwa ugula noma ubona ukuqubuka, shayela udokotela wakho. Ukungena njalo kukusiza ukuthi ulandelele ukuqhubeka kwakho futhi ulungise umthamo wakho.
Ithiphu: Qala ngethamo eliphansi bese ukhuphuka kancane. Lokhu kusiza umzimba wakho ulungise futhi kwehlisa amathuba okuba nemiphumela engemihle njengesicanucanu.

Ukusebenzisa umjovo we-semaglutide ngendlela efanele kukusiza ukuthi uthole imiphumela engcono kakhulu. I-Ozempic yokwehlisa isisindo kanye ne-Wegovy bobabili balandela lezi zinyathelo. Hlala ulandela iseluleko sikadokotela wakho ukuze uthole ukwelashwa okuphephile nokusebenzayo.
Ungase uzibuze ngemiphumela emibi ye-semaglutide ngaphambi kokuqala ukwelashwa. Abantu abaningi baqaphela izinkinga zesisu ezithambile. Isivivinyo se-STEP 5 sithole isicanucanu, isifo sohudo, ukuhlanza, nokuqunjelwa kwenzeka kaningi kubantu abasebenzisa i-semaglutide kunalabo abasebenzisa i-placebo. Lezi zinkinga zivame ukuvela lapho unyusa umthamo wakho. Zivame ukuhamba ngemva kwamasonto ambalwa. Akuvamile ukuthi udinge ukuyeka ukwelashwa ngenxa yalezi zimpawu.
Nali ithebula elibonisa ukuthi abantu bavame ukuyibika kaningi kangakanani imiphumela emibi yesisu:
Umphumela Omubi |
0.5 mg umthamo |
1 mg Umthamo |
Inani Elijovwayo |
Isicanucanu |
2.9% |
2.1% |
~2.4% |
Uhudo |
2.9% |
0% |
~1.2% |
Noma yimuphi umcimbi ohlobene |
4.9% |
N/A |
4.9% |
Imiphumela emibi eminingi imnene noma imaphakathi. Izinkinga ezinkulu azivamile. Azikho izehlakalo ze-pancreatitis ezibikiwe ezifundweni. Ungase uzizwe uguliswa yisisu sakho, kodwa ngokuvamile kuba ngcono njengoba umzimba wakho ulungisa.
Ithiphu: Qala ngethamo eliphansi bese ukhuphuka kancane. Lokhu kusiza umzimba wakho ukujwayela umuthi futhi kwehlisa amathuba okuba nezinkinga zesisu.
Ufuna ukwazi ukuthi i-semaglutide iphumelela kangakanani ekulahlekeni kwesisindo. Uzobona izinguquko esuthi sakho kuqala. Ezinsukwini ezimbalwa zokuqala, ungase uzizwe ulambile kancane. Ngenyanga yokuqala, ubona ukwehla okukhulu kwezinkanuko. Ukuncipha kwesisindo kuqala kancane. Ngesonto lesi-8 kuya ku-12, abantu abaningi balahlekelwa okungenani ama-5% esisindo somzimba wabo.
Nali umugqa wesikhathi walokho ongakulindela:
Umugqa wesikhathi (Amaviki) |
Kwenzakalani |
Ukwehla Kwesisindo Okujwayelekile |
1-4 |
Isifiso sokudla siyehla, izinguquko ezincane |
Okuncane |
8-12 |
Ukulungiswa komzimba, ukulahlekelwa okuqhubekayo |
~5% ngezinyanga ezi-3 |
17-20 |
Umthamo wesondlo ufinyelelwe |
Ukulahlekelwa okungaguquki |
20+ |
Ukuncipha kwesisindo kuyaqhubeka |
~ 10% ngezinyanga eziyisi-6 |
Izinyanga ezingu-12+ |
Isisindo siyazinza |
I-15-20% ngemuva konyaka ongu-1 |


Ungase ubone ushukela wegazi ongcono nempilo yenhliziyo njengoba ulahlekelwa isisindo. Ucwaningo lubonisa ukuthi i-semaglutide ikusiza ukuthi ulahlekelwe isisindo kuneminye imithi. Iphinde ithuthukise impilo yakho yomzimba. Imijovo yamasonto onke yenza kube lula ukunamathela ohlelweni lwakho.
Uthola imiphumela engcono kakhulu uma uhlanganisa i-semaglutide nokudla okunempilo nokuzivocavoca okuvamile. Abantu abaningi banciphisa isisindo uma behlala bekhuthele futhi belandela iseluleko sikadokotela wabo.
Ungalahlekelwa isisindo isikhathi eside ngomjovo we-semaglutide . Kuphinde kusize umzimba wakho ukuthi usebenzise amandla kangcono. Ucwaningo lukhombisa ukuthi yehlisa ushukela egazini futhi isiza inhliziyo yakho. Ingakusiza ukuthi ugcine isisindo sakho siphansi isikhathi eside. Ungase ubone inhliziyo yakho iba ngcono. Ungase ulahlekelwe isisindo kancane futhi kancane. Khuluma njalo nodokotela wakho ngaphambi kokuba uqale. Udokotela wakho uzokusiza ukuthi uhlale uphephile futhi ubheke imiphumela emibi. Cabanga ngezinto ezinhle nezimbi ngaphambi kokuba uqale ukwelashwa.


Ngokwempendulo yamakhasimende ethu angu-20+, ungakwazi ukulahlekelwa ngamaphawundi angu-3-8 phakathi neviki elingu-1. I-Ozempic yokwehlisa isisindo ikhombisa ukuqhubeka okuqhubekayo ngokuhamba kwesikhathi.
Ungakwazi ukuyeka, kodwa ukubuyisela isisindo ngokuvamile kwenzeka uma ungaqhubeki ekudleni. Ucwaningo lubonisa ukuthi abantu bagcina isisindo isikhathi eside lapho beqhubeka nomjovo we-semaglutide. Udokotela wakho angakusiza ukuthi unqume uhlelo olungcono kakhulu.
Kufanele ukugweme ukudla okunamafutha, okuthosiwe, noma okunoshukela omningi. Lokhu kungaphazamisa isisu sakho. Zama ukudla imifino eminingi, amaprotheni amancane, kanye nezinhlamvu. Ukuphuza amanzi kusiza ukunciphisa imiphumela emibi.
Yebo. Yonke imikhiqizo ye-AOMA yokuncipha kwesisindo ikhiqizwa ngaphansi kwezindinganiso eziqinile zemithi, okuyenza ifanelekele ukusetshenziswa masonto onke ngaphansi kokuqondisa kochwepheshe.
Uma uphuthelwa umthamo, thatha ngokushesha lapho ukhumbula. Uma sekusondele isikhathi somthamo wakho olandelayo, yeqa ogejiwe. Ungaphindi. Sebenzisa isikhumbuzi noma setha i-alamu ukukusiza ukhumbule.
Hlangana ne-AOMA
Ilabhorethri
Isigaba somkhiqizo
Amabhulogi